Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

All Monthly Communication Reports for AbbVie Corporation

RAMI FAYED, Vice President and General Manager, Canada (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results null-null of 155

  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Yash Nanda, Senior Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Research and Development, Economic Development
    Communication date: 2025-09-29
    Posted date: 2025-10-15
    Communication number: 15270-647699 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Shahad Khalladi, Senior Policy Advisor | Minister's office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Research and Development, Economic Development
    Communication date: 2025-08-25
    Posted date: 2025-09-15
    Communication number: 15270-644431 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Helena Jaczek, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Research and Development, Federal-Provincial Relations
    Communication date: 2025-08-14
    Posted date: 2025-09-15
    Communication number: 15270-643294 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Maggie Chi, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Research and Development, Economic Development
    Communication date: 2025-08-13
    Posted date: 2025-09-15
    Communication number: 15270-642840 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Manuela Tomic, Senior Policy Advisor | Minister's office | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Economic Development
    Communication date: 2025-07-25
    Posted date: 2025-08-15
    Communication number: 15270-641203 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Roy Karam, Director of Operations | Minister's office | Health Canada (HC)
    • Stephanie Claxton, Director of Policy | Minister's office | Health Canada (HC)

    Subject Matter of the communication: Health, Federal-Provincial Relations
    Communication date: 2025-05-12
    Posted date: 2025-06-16
    Communication number: 15270-635683 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    • Phillip Jennings, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry, Research and Development, Economic Development
    Communication date: 2025-02-18
    Posted date: 2025-03-15
    Communication number: 15270-633315 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Judith Seidman, Senator | Senate of Canada

    Subject Matter of the communication: Health, Research and Development, Federal-Provincial Relations
    Communication date: 2025-01-28
    Posted date: 2025-02-15
    Communication number: 15270-630037 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mohamed-Iqbal Ravalia, Senator | Senate of Canada

    Subject Matter of the communication: Health, Federal-Provincial Relations
    Communication date: 2024-11-27
    Posted date: 2024-12-16
    Communication number: 15270-624137 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eshan Naik, Director of Policy | Minister's office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Research and Development, Economic Development, Federal-Provincial Relations
    Communication date: 2024-11-21
    Posted date: 2024-12-16
    Communication number: 15270-623829 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Yves-François Blanchet, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2024-11-19
    Posted date: 2024-12-16
    Communication number: 15270-623826 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Cory Olishansky, Consul and Trade Commissioner | Consulate General of Canada in Chicago | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Research and Development, Economic Development
    Communication date: 2024-11-08
    Posted date: 2024-12-16
    Communication number: 15270-624138 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Valerie Bradford, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2024-09-24
    Posted date: 2024-10-15
    Communication number: 15270-615692 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Madeleine Fequiere, Consul General of Canada in Chicago | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2024-06-13
    Posted date: 2024-07-15
    Communication number: 15270-609737 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Scott Doidge, Director General | Non-Insured Health Benefits Directorate | Indigenous Services Canada (ISC)

    Subject Matter of the communication: Health
    Communication date: 2024-06-11
    Posted date: 2024-07-15
    Communication number: 15270-608374 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Harold Dremin, Chief of Investor Services | Invest in Canada Hub

    Subject Matter of the communication: Research and Development, Economic Development
    Communication date: 2024-06-04
    Posted date: 2024-07-15
    Communication number: 15270-606247 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Research and Development, Economic Development
    Communication date: 2024-06-03
    Posted date: 2024-07-15
    Communication number: 15270-606246 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • James Van Raalte, Executive Director RPCD | Treasury Board Of Canada Secretariat (TBS)

    Subject Matter of the communication: Intellectual Property
    Communication date: 2024-05-09
    Posted date: 2024-06-15
    Communication number: 15270-605658 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Francis Bilodeau, Associate Deputy Minister | Office of the Associate Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Andrea Johnston, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Etienne-Rene Massie, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2024-04-15
    Posted date: 2024-05-15
    Communication number: 15270-601161 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mark Schaan, Senior Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry
    Communication date: 2024-04-15
    Posted date: 2024-05-15
    Communication number: 15270-601160 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Christopher Johnstone, Assistant Deputy Minister | Health Canada (HC)
    • Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry, Research and Development
    Communication date: 2024-04-03
    Posted date: 2024-05-15
    Communication number: 15270-601209 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • William Messier, Quebec Advisor to the Minister of Innovation, Science and Industry | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2024-02-12
    Posted date: 2024-03-15
    Communication number: 15270-592450 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Helena Jaczek, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-12-19
    Posted date: 2024-01-15
    Communication number: 15270-589347 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kelley Parato, Director | Human Health Therapeutics Research Centre | National Research Council (NRC)
    • Bobby Kelly, Chief of Staff | Invest in Canada Hub
    • Laurel Broten, Chief Executive Officer | Invest in Canada Hub
    • Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2023-11-09
    Posted date: 2023-12-15
    Communication number: 15270-585719 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Paul Chiang, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-10-26
    Posted date: 2023-11-15
    Communication number: 15270-580505 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eshan Naik, Director of Policy | Office of the Minister of Health | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2023-10-20
    Posted date: 2023-11-15
    Communication number: 15270-580181 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stan Kutcher, Senator | Senate of Canada

    Subject Matter of the communication: Health
    Communication date: 2023-08-31
    Posted date: 2023-09-15
    Communication number: 15270-575644 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Yash Nanda, Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-07-27
    Posted date: 2023-08-18
    Communication number: 15270-575175 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Husain Aboghodieh, Policy Advisor | Global Affairs Canada (GAC)

    Subject Matter of the communication: Industry
    Communication date: 2023-05-17
    Posted date: 2023-06-15
    Communication number: 15270-566531 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mohamed-Iqbal Ravalia, Senator | Senate of Canada

    Subject Matter of the communication: Health
    Communication date: 2023-05-17
    Posted date: 2023-06-15
    Communication number: 15270-566530 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bianca Hossain, Sr Special Assistant | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-04-25
    Posted date: 2023-05-15
    Communication number: 15270-563714 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ed Morgan, Director General, Policy, Planning and International Affairs | Health Products and Food Branch | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-04-25
    Posted date: 2023-05-15
    Communication number: 15270-563713 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jocelyne Voisin, ADM | Strategic Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-04-25
    Posted date: 2023-05-15
    Communication number: 15270-563712 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eric Belair, Associate Assistant Deputy Minister | Strategic Policy Branch | Health Canada (HC)
    • Michelle Boudreau, Executive Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Suki Wong, Director General, Mental Health Directorate | Strategic Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-04-24
    Posted date: 2023-05-15
    Communication number: 15270-563711 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Majid Jowhari, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-04-20
    Posted date: 2023-05-15
    Communication number: 15270-563391 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Robert Kitchen, Member of Parlilament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2023-03-30
    Posted date: 2023-04-15
    Communication number: 15270-560863 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Susan Fitzpatrick, Head, Canada Drug Agency Transition Office | Office of Pharmaceuticals Management Strategies | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-03-21
    Posted date: 2023-04-15
    Communication number: 15270-560437 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jordan Ames-Sinclair, Special Assistant, Policy | Minister's Office | Health Canada (HC)
    • Emelyana Titarenko, Communications and Issues Manager | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-03-21
    Posted date: 2023-04-15
    Communication number: 15270-560435 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jamie Innes, Chief of Staff to the Minister | Intergovernmental Affairs Secretariat (IGA)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-12-14
    Posted date: 2023-01-16
    Communication number: 15270-552709 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jeff Waring, Director of Operations, Social Development Policy | Privy Council Office (PCO)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-12-14
    Posted date: 2023-01-16
    Communication number: 15270-552270 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Helen Gao, A/Chief of Staff | Indigenous Services Canada (ISC)

    Subject Matter of the communication: Aboriginal Affairs, Health
    Communication date: 2022-12-13
    Posted date: 2023-01-16
    Communication number: 15270-551201 (amended from 15270-551195) View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Steven MacKinnon, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-12-06
    Posted date: 2023-01-16
    Communication number: 15270-551200 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Robert Morrissey, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-12-06
    Posted date: 2023-01-16
    Communication number: 15270-551199 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Heath MacDonald, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-12-06
    Posted date: 2023-01-16
    Communication number: 15270-551198 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sameer Ahmed, Acting Consul General | Consulate General of Canada, Chicago | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-12-05
    Posted date: 2023-01-16
    Communication number: 15270-551194 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eric Belair, Associate Assistant Deputy Minister | Strategic Policy Branch | Health Canada (HC)
    • Michelle Boudreau, Executive Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-11-30
    Posted date: 2022-12-15
    Communication number: 15270-548735 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Yash Nanda, Senior Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-11-11
    Posted date: 2022-12-15
    Communication number: 15270-546187 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Shaili Patel, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-11-10
    Posted date: 2022-11-11
    Communication number: 15270-546186 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michelle Boudreau, Executive Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Michelle Mujoomdar, Director, Specialty Pharmaceuticals | Health Canada (HC)
    • Samir Khan, Director, Policy Division | Health Canada (HC)
    • Daniel MacDonald, Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-11-07
    Posted date: 2022-12-15
    Communication number: 15270-546188 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bianca Hossain, Sr Special Assistant | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-10-27
    Posted date: 2022-11-03
    Communication number: 15270-545249 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-10-26
    Posted date: 2022-11-03
    Communication number: 15270-545248 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Allison Haley, Director, Parliamentary Affairs | Office, Dr. Stephen Ellis | House of Commons
    • Dr. Stephen Ellis, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-10-25
    Posted date: 2022-11-03
    Communication number: 15270-545247 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jordan Ames-Sinclair, Special Assistant, Policy | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-09-06
    Posted date: 2022-09-06
    Communication number: 15270-540821 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bianca Hossain, Sr Special Assistant (Policy and Operations) | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-08-23
    Posted date: 2022-08-23
    Communication number: 15270-540434 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Yash Nanda, Senior Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-08-10
    Posted date: 2022-08-10
    Communication number: 15270-539492 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michelle Boudreau, Executive Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Samir Khan, Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-06-24
    Posted date: 2022-06-24
    Communication number: 15270-536285 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jean-Sebastien Bock, Director of Policy | Office of the Minister of Health | Health Canada (HC)
    • Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-06-21
    Posted date: 2022-06-24
    Communication number: 15270-536284 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Director General | Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-06-13
    Posted date: 2022-06-19
    Communication number: 15270-536040 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Hilary Peirce, Senior Policy Advisor | Office of the President of the Treasury Board | Treasury Board Of Canada Secretariat (TBS)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-06-01
    Posted date: 2022-06-03
    Communication number: 15270-533273 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jamie Kippen, Chief of Staff | Minister's Office | Health Canada (HC)
    • Jean-Sebastien Bock, Director of Policy | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-05-31
    Posted date: 2022-06-03
    Communication number: 15270-533272 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Adam Van Koeverden, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-05-31
    Posted date: 2022-06-03
    Communication number: 15270-533271 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ed Morgan, Director General | Policy, Planning and International Affairs Directorate | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-05-31
    Posted date: 2022-06-03
    Communication number: 15270-533270 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dr. Stephen Ellis, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-05-31
    Posted date: 2022-06-03
    Communication number: 15270-533269 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michelle Boudreau, Executive Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-05-30
    Posted date: 2022-06-03
    Communication number: 15270-533268 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-05-17
    Posted date: 2022-05-19
    Communication number: 15270-532600 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Industry
    Communication date: 2022-04-14
    Posted date: 2022-04-29
    Communication number: 15270-530329 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Darryl Patterson, Director General | Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-04-12
    Posted date: 2022-04-29
    Communication number: 15270-530327 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-03-17
    Posted date: 2022-03-21
    Communication number: 15270-526870 (amended from 15270-526869) View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba, Senior Policy Advisor - Quebec Desk | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-02-03
    Posted date: 2022-02-07
    Communication number: 15270-521145 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tyler Norman, Regional Advisor | Minister's Office | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-02-01
    Posted date: 2022-02-07
    Communication number: 15270-521144 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dylan Marando, Senior Policy Advisor | Minister's Office | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health
    Communication date: 2021-11-25
    Posted date: 2021-12-15
    Communication number: 15270-516377 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Wayne Robson, Acting Consul General of Canada in Chicago | Global Affairs Canada (GAC)
    • Molly Banuelos, Trade Commissioner/Life Sciences at Consulate General of Canada in Chicago | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-06-22
    Posted date: 2021-07-15
    Communication number: 15270-509471 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bob Saroya, Member of Parliament | House of Commons
    • Ryan Ouderkirk, Parliamentary Assistant | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-06-18
    Posted date: 2021-07-15
    Communication number: 15270-509226 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Justin Riemer, Assistant Deputy Minister, Alberta | Western Economic Diversification Canada | Western Economic Diversification Canada (WD)

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-06-07
    Posted date: 2021-07-15
    Communication number: 15270-506891 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Francis Scarpaleggia, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-05-11
    Posted date: 2021-06-15
    Communication number: 15270-506002 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bob Saroya, Member of Parliament | House of Commons
    • Christopher Poulos, Constituency Assistant | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-05-07
    Posted date: 2021-06-15
    Communication number: 15270-503795 (amended from 15270-503788) View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Holly Duggan, Stakeholder Relations Advisor | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-05-05
    Posted date: 2021-05-07
    Communication number: 15270-503794 (amended from 15270-503687) View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tom Kmiec, Member of Parliament | House of Commons
    • Alyssa Doig, Member's Assistant | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-04-20
    Posted date: 2021-05-15
    Communication number: 15270-503792 (amended from 15270-503075) View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Earl Dreeshen, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-04-15
    Posted date: 2021-05-15
    Communication number: 15270-503791 (amended from 15270-502621) View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Frank Baylis, Member of Parliament | House of Commons | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-01-30
    Posted date: 2019-02-04
    Communication number: 15270-444401 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Richard Botham, Assistant Deputy Minister | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry, Taxation and Finance
    Communication date: 2018-03-29
    Posted date: 2018-03-29
    Communication number: 15270-422901 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Frank Baylis, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2017-12-07
    Posted date: 2017-12-08
    Communication number: 15270-414874 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Health Canada (HC)
    • Abby Hoffman, Assistant Deputy Minister | Health Canada (HC)
    • Pierre Sabourin, Assistant Deputy Minister | Health Canada (HC)
    • Kendall Webber, Associate Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2017-11-14
    Posted date: 2017-11-24
    Communication number: 15270-414194 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kyle Peterson, House of Commons | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2017-11-09
    Posted date: 2017-11-24
    Communication number: 15270-414193 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rob Oliphant, House of Commons | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2017-11-08
    Posted date: 2017-11-24
    Communication number: 15270-414190 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Don Davies, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2017-11-08
    Posted date: 2017-11-24
    Communication number: 15270-414188 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rob Oliphant, Member of Parliament | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2017-10-31
    Posted date: 2017-11-24
    Communication number: 15270-414187 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Parvidner Sachdeva, Policy Advisor | Minister of Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2017-08-30
    Posted date: 2017-08-30
    Communication number: 15270-407186 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Emmanuella Lambropoulos, Member of Parliament | St-Laurent | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2017-08-29
    Posted date: 2017-08-30
    Communication number: 15270-407185 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Frank Baylis, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2017-01-19
    Posted date: 2017-02-07
    Communication number: 15270-393324 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Francis Scarpaleggia, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2017-01-19
    Posted date: 2017-02-07
    Communication number: 15270-393323 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Siddika Mithani, President | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2017-01-04
    Posted date: 2017-01-11
    Communication number: 15270-392304 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Paul Halucha, Assistant Deputy Minister | Life Sciences and Manufacturing Branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2016-11-01
    Posted date: 2016-11-04
    Communication number: 15270-386667 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Pierre Sabourin, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2016-11-01
    Posted date: 2016-11-04
    Communication number: 15270-386663 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ashleigh White, Special Assistant | Minister of Health's Office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2016-09-20
    Posted date: 2016-11-04
    Communication number: 15270-386661 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kyle Peterson, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2016-06-16
    Posted date: 2016-06-23
    Communication number: 15270-380295 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Don Davies, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
    Communication date: 2016-06-01
    Posted date: 2016-06-23
    Communication number: 15270-380294 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rob Oliphant, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2016-05-12
    Posted date: 2016-05-13
    Communication number: 15270-376874 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rachael Harder, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2016-05-11
    Posted date: 2016-05-13
    Communication number: 15270-376870 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kelvin K. Ogilvie, Honourable Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2016-04-13
    Posted date: 2016-04-14
    Communication number: 15270-374511 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nancy Greene Raine, Honourable Senator | Senate of Canada

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2016-04-12
    Posted date: 2016-04-14
    Communication number: 15270-374510 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Clements, Director of Communications | Office of the Minister of Health | Health Canada (HC)
    • Jesse Kancir, Policy Advisor | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2016-04-11
    Posted date: 2016-04-14
    Communication number: 15270-374512 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Robert Oliphant, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2016-04-11
    Posted date: 2016-04-14
    Communication number: 15270-374508 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Carol Hughes, Member of Parliament | House of Commons

    Subject Matter of the communication: Aboriginal Affairs, Health
    Communication date: 2016-03-09
    Posted date: 2016-03-14
    Communication number: 15270-371779 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • John Knubley, Deputy Minister | Industry Canada
    • Paul Halucha, Associate Assistant Deputy Minister | Strategic Policy Sector | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2015-04-15
    Posted date: 2015-05-06
    Communication number: 15270-352962 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Carol Hughes, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2015-01-28
    Posted date: 2015-02-16
    Communication number: 15270-347353 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Carolyn Bennett, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2015-01-27
    Posted date: 2015-02-16
    Communication number: 15270-347351 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ralph Goodalde, Member of Parliament | House of Commons

    Subject Matter of the communication: Aboriginal Affairs, Health
    Communication date: 2014-12-16
    Posted date: 2015-01-15
    Communication number: 15270-342997 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Libby Davies, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2014-10-21
    Posted date: 2014-11-15
    Communication number: 15270-338850 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kelvin Ogilvie, Senator | Senate of Canada

    Subject Matter of the communication: Health
    Communication date: 2014-10-20
    Posted date: 2014-11-15
    Communication number: 15270-338851 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Irene Mathyssen, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2014-10-20
    Posted date: 2014-11-15
    Communication number: 15270-338849 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Megan Leslie, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2014-09-25
    Posted date: 2014-11-15
    Communication number: 15270-338852 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Carolyn Bennett, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2014-09-04
    Posted date: 2014-09-15
    Communication number: 15270-333534 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Lois Brown, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2014-08-28
    Posted date: 2014-09-15
    Communication number: 15270-333533 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rainer Englehardt, Chief Science Officer | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2014-05-28
    Posted date: 2014-06-15
    Communication number: 15270-327994 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephane Dion, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2014-05-28
    Posted date: 2014-06-15
    Communication number: 15270-327992 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Joe Daniel, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2014-05-27
    Posted date: 2014-06-15
    Communication number: 15270-327991 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rod Bruinooge, Member of Parliament, Winnipeg South | House of Commons

    Subject Matter of the communication: Aboriginal Affairs, Health
    Communication date: 2013-04-30
    Posted date: 2013-05-15
    Communication number: 15270-271751 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ted Laking, Policy Advisor | Health Canada (HC)

    Subject Matter of the communication: Aboriginal Affairs, Health
    Communication date: 2013-04-30
    Posted date: 2013-05-15
    Communication number: 15270-271750 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rob Clarke, Member of Parliament, Desnethe-Missinippi-Churchill | House of Commons

    Subject Matter of the communication: Aboriginal Affairs, Health
    Communication date: 2013-04-30
    Posted date: 2013-05-15
    Communication number: 15270-271749 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Andrew Rankin, Policy Advisor | Finance Canada (FIN)
    • Samuel VanderVeer, Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Aboriginal Affairs, Health
    Communication date: 2012-10-31
    Posted date: 2012-11-15
    Communication number: 15270-245569 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Phil Harwood, Policy Advisor | Prime Minister's Office (PMO)
    • Drew Campbell, Manager, Stakeholder Relations | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Science and Technology
    Communication date: 2012-09-18
    Posted date: 2012-10-15
    Communication number: 15270-238810 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Colin Carrie, MP - Oshawa | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2012-09-18
    Posted date: 2012-10-15
    Communication number: 15270-238809 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Lisa Raitt, Minister of Labour | House of Commons
    • Michael Beaton, Director of Policy | House of Commons
    • Jana Regimbal, Special Assistant | House of Commons

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2012-08-07
    Posted date: 2012-09-15
    Communication number: 15270-235089 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Philip Jennings, Associate Assisstant Deputy Minister | Industry Canada

    Subject Matter of the communication: Health, Intellectual Property, Science and Technology
    Communication date: 2012-05-23
    Posted date: 2012-06-15
    Communication number: 15270-224988 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kellie Leitch, MP Simcoe-Grey | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2012-05-10
    Posted date: 2012-06-01
    Communication number: 15270-224987 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Phil Harwood, Policy Advisor | Prime Minister's Office (PMO)
    • Julie Gaudreau, Senior Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health
    Communication date: 2012-03-05
    Posted date: 2012-04-16
    Communication number: 15270-218307 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Leona Aglukkaq, Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2012-03-01
    Posted date: 2012-04-16
    Communication number: 15270-218308 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Andre Bellavance, MP - Richmond-Arthabaska | House of Commons

    Subject Matter of the communication: Intellectual Property, International Trade
    Communication date: 2012-03-01
    Posted date: 2012-04-16
    Communication number: 15270-211352 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Carol Hughes, MP - Algoma--Manitoulin--Kapuskasing | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2012-03-01
    Posted date: 2012-04-16
    Communication number: 15270-211351 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephane Dion, MP- Ville-St-Laurent-Cartierville | House of Commons

    Subject Matter of the communication: Intellectual Property, International Trade
    Communication date: 2012-03-01
    Posted date: 2012-04-16
    Communication number: 15270-211350 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Andrew Rankin, Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Health
    Communication date: 2012-02-15
    Posted date: 2012-03-16
    Communication number: 15270-211349 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rob Clark, MP - Desnethé—Missinippi—Churchill River | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2012-02-02
    Posted date: 2012-03-16
    Communication number: 15270-211348 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dean Del Mastro, MP - Peterborough | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2012-02-02
    Posted date: 2012-03-16
    Communication number: 15270-211347 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dany Morin, MP - Chicoutimi--Le Fjord | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2011-11-17
    Posted date: 2011-12-16
    Communication number: 15270-200108 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rob Clarke, MP - Desnethé--Missinippi--Churchill River, | House of Commons
    • Shelly Glover, MP - Saint-Boniface | House of Commons
    • Peter Penashue, MP - Labrador | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2011-11-03
    Posted date: 2011-12-16
    Communication number: 15270-192471 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Andrew Rankin, Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Health
    Communication date: 2011-11-03
    Posted date: 2011-12-16
    Communication number: 15270-192469 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kellie Leitch, MP Simcoe-Grey | House of Commons
    • Colin Carrie, MP Oshawa | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2011-11-01
    Posted date: 2011-12-16
    Communication number: 15270-191604 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kirsty Duncan, MP Etobicoke North | House of Commons

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2011-10-31
    Posted date: 2011-11-16
    Communication number: 15270-191603 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • John McCallum, MP Markham-Unionville | House of Commons

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2011-10-24
    Posted date: 2011-11-16
    Communication number: 15270-191599 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Brad Butt, MP Mississauga-Streetsville | House of Commons

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2011-10-19
    Posted date: 2011-11-16
    Communication number: 15270-191597 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gord Brown, MP Leeds-Grenville | House of Commons

    Subject Matter of the communication: Health, Intellectual Property
    Communication date: 2011-10-18
    Posted date: 2011-11-16
    Communication number: 15270-191593 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Andrea McGuigan, Policy Advisor | Prime Minister's Office (PMO)
    • Sean Speer, Director, Stakeholder Relations | Prime Minister's Office (PMO)
    • Gary Goodyear, Minister of State for Science and Technology | Industry Canada
    • Ève Peclet, Member of Parliament | La Point-de-l'ile | House of Commons
    • Kellie Leitch, Member of Parliament | Simcoe-Grey | House of Commons
    • Glenn Thibault, Member of Parliament | Sudbury | House of Commons

    Subject Matter of the communication: Health, Intellectual Property, Taxation and Finance
    Communication date: 2011-09-20
    Posted date: 2011-10-16
    Communication number: 15270-188028 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Raymond Coté, Member of Parliament | Beauport Limoilou | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2011-09-20
    Posted date: 2011-10-16
    Communication number: 15270-188027 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ed Fast, Minister of International Trade and for the Asia-Pacific Gateway | Foreign Affairs and International Trade Canada (DFAITC)
    • Michelle Boudreau, Executive Director, Patented Medicine Prices Review Board | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2011-09-13
    Posted date: 2011-10-16
    Communication number: 15270-188448 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rob Clarke, Member of Parliament | Desnethé–Missinippi–Churchill River | House of Commons

    Subject Matter of the communication: Aboriginal Affairs, Health
    Communication date: 2011-09-08
    Posted date: 2011-10-16
    Communication number: 15270-188045 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Lois Brown, Member of Parliament Newmarket | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2011-06-01
    Posted date: 2011-07-16
    Communication number: 15270-174284 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Francis Scarpalegia, MP: Lac-Saint-Louis | House of Commons
    • Stephane Dion, MP: Saint Laurent-Cartierville | House of Commons
    • John McCallum, MP: Markham-Unionville | House of Commons

    Subject Matter of the communication: Intellectual Property
    Communication date: 2011-03-03
    Posted date: 2011-04-16
    Communication number: 15270-169186 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Luc Malo, MP: Vercheres/Les Patriots | House of Commons
    • Andre Bellavance, MP - Richmond-Arthabaska | House of Commons

    Subject Matter of the communication: Intellectual Property
    Communication date: 2011-03-02
    Posted date: 2011-04-16
    Communication number: 15270-169185 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gord Brown, MP - Leeds-Grenville | House of Commons

    Subject Matter of the communication: Industry, Intellectual Property
    Communication date: 2010-10-18
    Posted date: 2010-11-01
    Communication number: 15270-158172 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rob Clarke, Member of Parliament | Desnethé–Missinippi–Churchill River | House of Commons
    • Rob Clarke, Member of Parliament | Houe of Commons | House of Commons

    Subject Matter of the communication: Health care policy
    Communication date: 2010-09-08
    Posted date: 2011-10-03
    Communication number: 15270-188024 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Leah Canning, Director of Policy | Health Canada | Health Canada (HC)

    Subject Matter of the communication: Health care policy
    Communication date: 2010-06-25
    Posted date: 2010-07-19
    Communication number: 15270-152497 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Laurie Throness, Minister's Chief of Staff | Minister's Office INAC | Aboriginal Affairs and Northern Development Canada

    Subject Matter of the communication: Aboriginal Affairs, Health
    Communication date: 2010-05-06
    Posted date: 2010-05-17
    Communication number: 15270-148376 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Leah Canning, Senior Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Aboriginal Affairs, Health care policy
    Communication date: 2010-04-12
    Posted date: 2010-05-17
    Communication number: 15270-148373 View monthly communication report
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dave Forestell, Policy Advisor | Prime Minister's Office | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health
    Communication date: 2010-03-31
    Posted date: 2010-04-15
    Communication number: 15270-146114 View monthly communication report
Date Modified: